Literature DB >> 35840874

Elusive amines: migraine depends on biochemical abnormalities.

Giovanni D'Andrea1, Antonina Gucciardi2, Alberta Leon3.   

Abstract

The pathogenesis of migraine, as well as cluster headache (CH), is yet a debated question. In this review, we discuss the possible role of tyrosine and tryptophan metabolism in the pathogenesis of primary headaches, including the abnormalities in the synthesis of neurotransmitters. High level of dopamine, low level of norepinephrine, and very elevated levels of octopamine and synephrine were found in the plasma of episodic migraine without aura. We hypothesize that the imbalance between the levels of neurotransmitters and elusive amines synthesis is due to a metabolic shift directing tyrosine toward increased decarboxylase and reduced hydroxylase enzyme activities, favored by a state of neuronal hyperexcitability and a reduced mitochondrial activity. In addition, we present biochemical studies performed in chronic migraine (CM) and chronic tension-type headache patients (CTTH) to verify if the same anomalies are present in these primary headaches and, if so, their possible role in the chronicity process of CM and CTTH. The results show that important abnormalities of tyrosine-related metabolites are present only in CM patients while tryptamine plasma levels were found significantly lower in both CM and CTTH patients. Because of this, we propose that migraine and, possibly, CH attacks derive from neurotransmitter and neuromodulator metabolic abnormalities in a hyperexcitable and hypoenergetic brain that spread from the frontal lobe, downstream, resulting in abnormally activated nuclei of the pain matrix. The low tryptamine plasma levels found in CM and CTTH patients suggest that these two primary chronic headaches are characterized by a common insufficient serotoninergic control of the pain threshold.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Migraine; Octopamine; Tryptamine; Tyramine

Year:  2022        PMID: 35840874     DOI: 10.1007/s10072-022-06241-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  43 in total

Review 1.  Descending control of pain.

Authors:  Mark J Millan
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

Review 2.  Elusive amines and primary headaches: historical background and prospectives.

Authors:  G D'Andrea; S Terrazzino; D Fortin; P Cocco; T Balbi; A Leon
Journal:  Neurol Sci       Date:  2003-05       Impact factor: 3.307

3.  The concept of migraine as a state of central neuronal hyperexcitability.

Authors:  K M Welch; G D'Andrea; N Tepley; G Barkley; N M Ramadan
Journal:  Neurol Clin       Date:  1990-11       Impact factor: 3.806

4.  Platelet and plasma levels of glutamate and glutamine in migraine with and without aura.

Authors:  A R Cananzi; G D'Andrea; F Perini; F Zamberlan; K M Welch
Journal:  Cephalalgia       Date:  1995-04       Impact factor: 6.292

5.  Platelet levels of glutamate and aspartate in normal subjects.

Authors:  G D'Andrea; A R Canazi; F Ferro-Milone; R Joseph; S Grunfeld; K M Welch
Journal:  Stroke       Date:  1989-02       Impact factor: 7.914

6.  Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine.

Authors:  S K Aurora; B K Ahmad; K M Welch; P Bhardhwaj; N M Ramadan
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

7.  Migraine. A biobehavioral disorder.

Authors:  K M Welch
Journal:  Arch Neurol       Date:  1987-03

Review 8.  Octopamine.

Authors:  J Axelrod; J M Saavedra
Journal:  Nature       Date:  1977-02-10       Impact factor: 49.962

9.  Motor and visual cortical excitability in migraineurs patients with or without aura: transcranial magnetic stimulation.

Authors:  Eman M Khedr; Mohamed A Ahmed; Khaled A Mohamed
Journal:  Neurophysiol Clin       Date:  2006-02-02       Impact factor: 3.734

10.  Multisensorial Perception in Chronic Migraine and the Role of Medication Overuse.

Authors:  Simona Maccora; Nadia Bolognini; Giuseppe Cosentino; Roberta Baschi; Giuseppe Vallar; Brigida Fierro; Filippo Brighina
Journal:  J Pain       Date:  2020-01-03       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.